Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Mild oxidative stress can prevent hair loss from chemotherapy.

Anti-androgens might help reduce COVID-19 severity in men.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Bicalutamide may help treat female pattern hair loss.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The document concludes that hair loss has many causes and treatments vary, including medication for pattern baldness and addressing underlying issues for other types.

Biofield Energy Treatment, specifically The Trivedi Effect®, can potentially enhance hair growth by increasing the growth activity of human dermal papilla cells.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.